An interventional study of Early catheter removal and Later catheter removal in Urethral Stricture, Bulbar, sponsored by Jane Kurtzman. Enrolling by invitation at 4 sites in United States. Open to male participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-02-27.
Sponsored by Jane Kurtzman · Not applicable, Interventional, and Other
The goal of this clinical trial is to learn when is the best time to remove a Foley catheter (tube used to drain urine from the bladder) after surgery in adult men who have a specific type of urethral stricture disease (narrowing of the tube that carries urine from the body). The main question it aims to answer is:
- Is there a difference between removing the catheter at 7-10 days versus 18-21 days?
Researchers will compare Foley removal at 7-10 days to removal at 18-21 days to see if there is a difference in problems after surgery or if the narrowing returns.
Participants will:
68 studies on the registry are indexed under Urethral Stricture; 23 are open to participants now.
This study's planned enrollment of 320 is above the median of 60 across 53 interventional studies indexed under Urethral Stricture.
Browse Urethral Stricture studies →This is the only study on the registry with Jane Kurtzman as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: Early catheter removal
Device: Later catheter removal
Removal after 7-10 days
Removal after 18-21 days
Number of Participants who Experience a Stricture Recurrence
Time frame: 1 year
Number of Participants who Experience a Perioperative Complication
Time frame: From Foley insertion to Foley removal
Rate of Retrograde Urethrograms Performed on Day of Foley Removal
Time frame: Foley Removal
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.